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Cornelia de Lange syndromeTo the Editor:
B cells rely on a broad receptor repertoire to provide protection
against a wide range of pathogens. This is in part achieved
through V(D)J recombination, which, by assembling various
combinations of variable (V), diversity (D), and joining (J) genes,
creates different IgV regions.1 The recombination processes is
initiated by recombination-activating gene (RAG) 1/RAG2 en-
zymes and requires a functional nonhomologous end-joining
(NHEJ) machinery. B cells can further diversify their IgV regions
through somatic hypermutation (SHM) to improve affinity
between the antibody and antigen and switch the isotype of
antibody produced by class-switch recombination (CSR). Both
processes are initiated by activation-induced cytidine deaminase
(AID) and rely on transcription and a number of DNA repair
mechanisms.
Cornelia de Lange syndrome (CdLS) is a rare multisystem
developmental disorder characterized by typical facial features,
intellectual disability, and multiple congenital anomalies.2 Most
patients with CdLS have deleterious mutations in the gene
encoding the cohesin loader Nipped-B-like (NIPBL), but
mutations in the other cohesin-related genes SMC1A, SMC3,
PDS5B, RAD21, or HDAC8 have also been identified in selected
patients. Cohesin has been implicated in regulation of sister
chromatid cohesion, transcription, long-range gene interactions,
and DNA repair.3
Aberrant CSR patterns have been observed in B cells from
patients with NIPBL mutations.4 Here we further investigated
whether V(D)J recombination or SHM is affected in patients
with CdLS. In chromosome-integrated V(D)J reporter assays,
a reduced substrate recombination efficiency was observed in
NIPBL knockdown human fibroblast or murine pro-B cells (see
Fig E1 and theMethods section in this article’s Online Repository
at www.jacionline.org).
We next analyzed the IGH repertoire in 5 patients with
NIPBL mutations and 3 patients with SMC1A mutations
with CdLS (see Table E1 in this article’s Online Repository at
www.jacionline.org). The overall diversity of the IGHV
repertoire, which is estimated by either the proportion of
sequences with a unique complementary determining region 3
(CDR3) divided by the total number of sequences or by
cumulative 50% of the total CDR3s in the samples (diversity 50
[D50]), which is a measurement of the evenness of the
distribution of B-cell clones, was significantly lower in patients
with NIPBL or SMC1A mutations (Fig 1, A and B). Thus the
patients with CdLS had a reduced overall diversity of their
IGHV regions, with an overrepresentation of large B-cell clones.
Furthermore, in patients with NIPBL mutations with the
classical form of the disease and in patients with SMC1A 2017 The Authors. Published by Elsevier Inc. on behalf of the American Academy of
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ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).mutations, the frequency of IGHV genes located in the most
proximal one third of the IGH locus (about 250 kb) was increased
(Fig 1, C, and see Fig E2 in this article’s Online Repository at
www.jacionline.org). The observed skewed pattern of VH genes
in the patients is likely to be a result of B cell–intrinsic
changes because only sequences resulting from unproductive
rearrangement (successfully rearranged but out of reading frame
or containing stop codons) were included in this analysis, and an
influence of antigen selection can thus be excluded.
The overall mutation frequency in the unproductive and most
commonly mutated IGHV genes was also reduced in the patients
with CdLS, reaching statistical significance for the group with an
NIPBL mutation (Fig 2, A). The proportion of unmutated
sequences was increased in the patients with NIPBL mutations,
especially in those with the classical form of the disease (Fig 2,
A). However, the pattern of base pair substitution in the V regions
was largely normal in the patients (Fig 2, B).
Our data suggest that the cohesion-associated proteins NIPBL
and SMC1A are involved in regulation of V(D)J recombination in
human B cells, possibly through regulation of locus contraction.
Increased use of proximally located IghV genes has previously
been observed in mice deficient in factors associated with locus
contraction, such as Ikaros, Yin Yang 1, and Pax5, and the cohesin
interaction partner CCCTC-binding factor has been suggested to
regulate locus contraction and V(D)J recombination at the mouse
Igh locus.5-7
Another possible explanation of how NIPBL/SMC1A could
affect V(D)J recombination could be a change in regulation of
DNA repair. We have previously observed a correlation between
heterozygous NIPBL loss-of-function mutations and increased
sensitivity to g-radiation and a shift toward use of
microhomology-based end-joining during CSR, suggesting that
NIPBL regulates the NHEJ process.4 However, the V(D)J coding
junctions generated in vivo in patients with CdLS showed a
normal repair pattern (see Table E2 in this article’s Online
Repository at www.jacionline.org). Furthermore, expression of
a number of key V(D)J recombination factors was largely normal
in NIPBL knockdown cells (see Fig E3, B, in this article’s Online
Repository at www.jacionline.org). Thus the core NHEJ
machinery appears to be retained in patients with CdLS.
We also found a reduced frequency of mutations within the
IGHV regions in patients with CdLS. NIPBL and SMC1A could
both be involved in the SHM process through regulation of
transcription or RNA polymerase pausing, which promotes
formation of single-stranded DNA and AID targeting. In support
of this notion, there was a reduced number of mutations observed
in the RGYW motifs (containing the AID hotspot in the bottom
strand) in NIPBL1/2 and SMC1A2 cells, suggesting an impaired
mutagenesis of C residues on the bottom strand (Fig 2, C).
We have previously observed the opposite pattern in NBS1-
deficient cells.8 Thus the targeting of AID and/or linked repair
seem to be asymmetric during SHM, and this can be regulated
by a number of factors, including the cohesin-associated factors.
CdLS is not traditionally considered an immunodeficiency
disorder, but these patients have an increased prevalence of
severe infections.9 Immunodeficiency, including mild B-cell
lymphopenia, reduced switched memory B-cell numbers, and/or
reduced serum immunoglobulin levels, has been observed in
previous case reports9 and in our own patients (see Table E3 in
this article’s Online Repository at www.jacionline.org). Complete
knockout of NIPBL is incompatible with survival, and
FIG 1. Reduced IGH diversities and increased use of proximal IGHV genes in patients with CdLS. A and B,
Diversities (unique/total CDR3s; Fig 1,A) and the proportion of unique B-cell clones (Fig 1,B) that account for
D50. Significant differences compared with control values: **P < .01 and ***P < .001, Student t test. Each
dot represents 1 subject. Black or white squares indicate patients with NIPBL mutations with the classical
or mild form of disease, respectively. C, Average frequencies of proximal, middle, and distal V genes (in
relation to D and J genes) in patients with CdLS. Schematic picture (not to scale) of the IGH locus is shown
at top. Proximal, middle, or distal V gene groups each encompass approximately 250 kb of the IGHV locus
and contain 15, 20, and 19 functional V genes, respectively. The number of sequences used in the analysis is
indicated below each group. The proportion of proximal, middle, or distal V genes for each subject was
regarded as 1 data point, and the patient and control groups were then compared by using the Student
t test. Significant differences compared with control values are indicated by arrows. [ and Y, Increased
or decreased compared with control values, respectively.
J ALLERGY CLIN IMMUNOL
VOLUME 141, NUMBER 1
LETTERS TO THE EDITOR 409heterozygous nonsense mutation or frameshift deletions in NIPBL
are usually associated with a more severe clinical phenotype than
those with missense mutations and in frame deletions (classical vs
mild form), suggesting a dose-dependent role of the cohesin-
associated proteins. The SMC1A mutations are missense or
in-frame deletions and are generally associated with a milder
CdLS phenotype. Thus mutations identified in patients with CdLS
can be considered hypomorphic and/or result in haploinsufficiency,
and a more significant alteration in immunoglobulin gene diversifi-
cations and a more severe immunodeficiency would be expected in
the event of a complete loss of these cohesin-associated proteins.
In summary, the less diversified VH genes caused by reduced
efficiency of V(D)J recombination together with inefficient
CSR efficiency might contribute to the frequent infections in
patients with CdLS.
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FIG 2. Mutation frequency and substitution pattern in IGHV regions from NIPBL1/2 and SMC1A2 B cells. A,
Mutation frequencies are shown at left. Each dot represents 1 subject. Black or white squares indicate
NIPBL1/2 patients with a classical or mild form of disease, respectively. Percentages of sequences with 0,
1 to 5, 6 to 10, or more than 10 mutations in the IGHV regions from control, NIPBL1/2, or SMC1A2 cells
are depicted in pie charts at right. IGHV1-18, IGHV1-69, IGHV3-23, IGHV3-30, IGHV3-33, and IGHV4-34
sequences were included in the analysis. Significant differences compared with control values: *P < .05,
Student t test. B, Frequencies of substitutions in the IGHV genes (x2 test, Bonferroni corrected). C, Frequency
of mutations within W(A/T)R(G/A)CY(C/T)/RGYW motifs in the IGHV genes analyzed in Fig 2, A. Asterisks
indicate significant differences between NIPBL1/2 (black asterisks) and SMC1A2 (gray asterisks) compared
with control cells. *P < .05, x2 test, Bonferroni corrected.
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Around the Mediterranean basin, Cupressaceae pollen is
considered as the primary cause of respiratory allergies with
symptoms of rhinoconjunctivitis, chronic cough, and asthma.1
The pollinosis can be severe including infectious complications,
partly due to winter pathologies occurring within cypress
pollinating period.2 In Southern France, a pollen food-associated
syndrome (PFAS) was described involving cypress pollen and
peach and/or citrus sensitizations inducing mainly oral syndromeFIG 1. A, Mass spectrometry analysis of in-gel–separ
pollen extract. The gel was run under reducing con
Methods section. B, Sequence alignment of peamac
Solanum tuberosum, and GRP from Theobroma cacao
correspond to the peptides identified in mass spectrom
point. SC (%) percent coverage. *Amino acid identit
without signal peptide as described in Kuddus et al.4but also urticaria and angioedema. Up to now, the cross-reactive
allergen at the basis of this syndrome has not yet been unraveled.
Besides the 4 groups of allergens already described in the various
Cupressaceae species, an as yet unidentified basic allergen of
14 kDa (BP14), overexpressed in Cupressus sempervirens pollen
and different from a lipid transfer protein, was found to sensitize
37% of cypress pollen allergic patients (CPAPs) in Southern
France.3 The BP14 IgE epitopes are not related to
cross-reactive carbohydrate determinants and are heat resistant
but destroyed under reducing conditions.
To identify BP14, proteins extracted from C sempervirens
pollen were run in SDS-PAGE and the corresponding band was
submitted to mass spectrometry analysis (see this article’s
Methods section in the Online Repository at www.jacionline.
org). Except a contaminant peptide of polygalacturonase, 2
overlapping peptides of the gibberellin-regulated protein (GRP)
peamaclein (Pru p 7 from peach) were found: R.CLKYCGIC-
CEK.C and K.YCGICCEK.C. Furthermore, 1 very similar
peptide of the GRP of Theobroma cacao was identified:
R.CLKYCGICCK.K (Fig 1, A). Using the Basic Local Alignment
Search Tool algorithm, the identified peptides were evidenced in
proteins of the snakin/GRP family from various plant species.
One of them, the snakin-1 from potato, produced in recombinant
form4 and sharing 82.5% sequence identity with Pru p 7 and
79.4% with the GRP of Theobroma cacao (Fig 1, B), was tested
in direct and inhibition western blots for its binding with serum
IgE from CPAP. Out of 30 CPAP sera, all those expressing IgE
to BP14 exhibited IgE reactivity to snakin-1 (n 5 15) (Fig 2, A
and B). No IgE binding was observed in 14 of the 15 sera tested
from BP14-negative CPAPs. One serum (no. 31), tested negative
for BP14, was positive for snakin-1. Available clinical data from
patients are given in Table E1 in this article’s Online Repository at
www.jacionline.org. Similarly to BP14, the reduction of snakin-1
resulted in decreased apparent molecular mass and abolished IgE
reactivity (Fig 2, C), pointing out the presence of conformational
IgE epitopes, which is in agreement with the highly foldedated BP14 proteins from Cupressus sempervirens
dition. For detailed information, see this article’s
lein from Prunus persica (P86888), snakin-1 from
(GRP Theo, A0A061FGF7). The enlighted sequences
etry analysis. MW, Molecular weight; pI, isoelectric
y with peamaclein sequence. Snakin-1 sequence
